If approved, Xolair would be the first medicine to reduce allergic reactions to multiple foods following an accidental exposure
Syngene has completed a payment of Rs. 158.2 crores on December 22, 2023 in addition to the initial payment of Rs. 395 crores made on December 1, 2023
World HRD Congress is a well-known international body of Management Studies
This PAI-cum-GMP USFDA inspection was conducted from December 14 to December 22, 2023
If approved, patritumab deruxtecan would be a first-in-class HER3 directed DXd antibody drug conjugate for these patients
Trinity has availed credit facility from Investec for Business for their working capital requirements of Rs. 31.5 crore
Development services for gene and cell therapies is planned to begin first in 2025
NPPA fixes the ceiling price of scheduled formulations as per the extant provisions of DPCO, 201
KBR will provide outreach, education and data analytics to support critical neuroscience research for the prevention and treatment of military members with CTE
The bioprocess business will continue to pioneer contributions to safety and productivity in the manufacture of biotherapeutics
Subscribe To Our Newsletter & Stay Updated
